Skip to main content
Professional Technical IVT

euglycemic ketoacidosis

Pronunciation: you-gly-SEE-mik

A life-threatening condition characterized by ketoacidosis with normal or only mildly elevated blood glucose levels, often associated with SGLT2 inhibitor use.

Full Definition

Euglycemic ketoacidosis (euDKA) is a serious metabolic emergency characterized by the presence of ketoacidosis (elevated ketones, metabolic acidosis) with blood glucose levels below the typical threshold for diabetic ketoacidosis (<250 mg/dL or 13.9 mmol/L). This condition has gained prominence with the widespread use of SGLT2 inhibitors, which can trigger ketogenesis while simultaneously lowering glucose levels through glucosuria. EuDKA can also occur in patients with prolonged fasting, severe illness, or other metabolic stressors. The condition is particularly dangerous because the normal glucose levels may delay recognition and treatment. Prompt identification requires measurement of ketones in patients presenting with metabolic acidosis, regardless of glucose levels.

Usage

Usage note: Often abbreviated as euDKA in clinical practice. Hyphenate when used as an adjective.

In Context

  • "The emergency department physician suspected euglycemic ketoacidosis given the patient's metabolic acidosis and recent SGLT2 inhibitor use." — Emergency medicine case report
  • "Healthcare providers should maintain high suspicion for euglycemic ketoacidosis in diabetic patients with unexplained acidosis." — Clinical safety alert

Also known as

euDKA normoglycemic ketoacidosis

Contrasted with

hyperglycemic ketoacidosis

Don't confuse with

diabetic ketoacidosis starvation ketosis

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON